Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amebiasis and "nonpathogenic" intestinal protozoa

J N Aucott1, J I Ravdin

  • 1Department of Medicine, Case Western University School of Medicine, Cleveland, Ohio.

Infectious Disease Clinics of North America
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lyme disease and post-treatment Lyme disease syndrome: the neglected disease in our own backyard.

Public health·2014
Same author

The problem of retaining clinical teachers in academic medicine.

Perspectives in biology and medicine·2001
Same author

Comparison of antigen-capture ELISA to stool-culture methods for the detection of asymptomatic Entamoeba species infection in Kafer Daoud, Egypt.

The American journal of tropical medicine and hygiene·2001
Same author

Distribution of research awards from the National Institutes of Health among medical schools.

The New England journal of medicine·2000
Same author

Diagnosis of invasive amebiasis by enzyme-linked immunosorbent assay of saliva to detect amebic lectin antigen and anti-lectin immunoglobulin G antibodies.

Journal of clinical microbiology·2000
Same author

Clinician-educators in academic medical centers.

The New England journal of medicine·2000
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Intestinal protozoa infections are common, ranging from asymptomatic to severe disease. Effective amebiasis management requires understanding risk factors, clinical signs, and anti-amebic drug actions for various protozoan pathogens.

Area of Science:

  • * Medical Parasitology
  • * Infectious Diseases
  • * Gastroenterology

Background:

  • * Intestinal protozoal infections are prevalent globally in humans.
  • * These infections can manifest as asymptomatic colonization or symptomatic intestinal disease.
  • * Entamoeba histolytica is a key example of an invasive colonic protozoal pathogen.

Observation:

  • * Diagnosis and treatment of amebiasis depend on recognizing epidemiologic risk factors and clinical presentations.
  • * A systematic diagnostic approach is crucial for effective patient management.
  • * Understanding the mechanisms and applications of anti-amebic drugs is essential.

Findings:

  • * Entamoeba histolytica is a primary focus for invasive intestinal protozoal infections.

Related Experiment Videos

  • * Knowledge of amebiasis treatment informs the approach to less common pathogens like Dientamoeba fragilis and Balantidium coli.
  • * The study also considers 'nonpathogenic' protozoa such as Blastocystis hominis and Entamoeba coli.

    • Implications:

    • * This framework aids in diagnosing and treating a spectrum of intestinal protozoal infections.
    • * It highlights the importance of targeted therapeutic strategies for different protozoan species.
    • * Improved understanding can lead to better patient outcomes and public health strategies for protozoal diseases.